BRISTOL MYERS SQUIBB CO
NYSE · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Bristol Myers Squibb develops, manufactures, and markets prescription pharmaceuticals, including treatments for cancer, cardiovascular disease, immunology, and neuroscience. Its product portfolio includes drugs such as Eliquis, Opdivo, and Revlimid, sold to hospitals, pharmacies, and distributors worldwide.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Massacesi CristianEVP,Chief Med Offr,Head of Dev | Sell | $403K | 6,249at $64.57 | Sep 9, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
| Member | Chamber | Type | Amount | Date |
|---|---|---|---|---|
| Alan ArmstrongArmstrong, Alan (Senator) | Senate | Buy | $1,001 - $15,000 | Mar 27, 2026 |
| Thomas H TubervilleTuberville, Tommy (Senator) | Senate | Sell | $1,001 - $15,000 | Apr 15, 2025 |
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable BMY activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.